was read the article
array:24 [ "pii" => "S2013251421000274" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2020.05.006" "estado" => "S300" "fechaPublicacion" => "2021-03-01" "aid" => "725" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2021;41:223-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0211699520300643" "issn" => "02116995" "doi" => "10.1016/j.nefro.2020.05.002" "estado" => "S300" "fechaPublicacion" => "2021-03-01" "aid" => "725" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia. 2021;41:223-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "¿Es la hiporrespuesta inmune de la uremia un factor de protección contra la neumonía grave por COVID-19?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "223" "paginaFinal" => "224" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Is the immune hyporesponsiveness of uremic patients a protective factor for severe COVID-19 pneumonia?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Enrique A. Florit, Fritz Diekmann" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Enrique A." "apellidos" => "Florit" ] 1 => array:2 [ "nombre" => "Fritz" "apellidos" => "Diekmann" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251421000274" "doi" => "10.1016/j.nefroe.2020.05.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251421000274?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699520300643?idApp=UINPBA000064" "url" => "/02116995/0000004100000002/v2_202105290635/S0211699520300643/v2_202105290635/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2013251421000420" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2020.11.012" "estado" => "S300" "fechaPublicacion" => "2021-03-01" "aid" => "801" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2021;41:224-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Kidneys also speak Spanish" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "224" "paginaFinal" => "226" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Los riñones también hablan español" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jordi Bover, Ricardo Bosch, Pablo Ureña, Pedro Trinidad, Aquiles Jara, José Luis Górriz, Mónica Furlano, Ramón A. García-Trabanino, Rosana Gelpi, Alberto Ortiz, César A. Restrepo, Maya Sánchez-Baya, Carolt Arana, Marián Goicoechea, Verónica Coll, Julián Segura, Orlando Gutiérrez, Emilio Sánchez, Alejandro Ferreiro, Rafael García-Maset" "autores" => array:20 [ 0 => array:2 [ "nombre" => "Jordi" "apellidos" => "Bover" ] 1 => array:2 [ "nombre" => "Ricardo" "apellidos" => "Bosch" ] 2 => array:2 [ "nombre" => "Pablo" "apellidos" => "Ureña" ] 3 => array:2 [ "nombre" => "Pedro" "apellidos" => "Trinidad" ] 4 => array:2 [ "nombre" => "Aquiles" "apellidos" => "Jara" ] 5 => array:2 [ "nombre" => "José Luis" "apellidos" => "Górriz" ] 6 => array:2 [ "nombre" => "Mónica" "apellidos" => "Furlano" ] 7 => array:2 [ "nombre" => "Ramón A." "apellidos" => "García-Trabanino" ] 8 => array:2 [ "nombre" => "Rosana" "apellidos" => "Gelpi" ] 9 => array:2 [ "nombre" => "Alberto" "apellidos" => "Ortiz" ] 10 => array:2 [ "nombre" => "César A." "apellidos" => "Restrepo" ] 11 => array:2 [ "nombre" => "Maya" "apellidos" => "Sánchez-Baya" ] 12 => array:2 [ "nombre" => "Carolt" "apellidos" => "Arana" ] 13 => array:2 [ "nombre" => "Marián" "apellidos" => "Goicoechea" ] 14 => array:2 [ "nombre" => "Verónica" "apellidos" => "Coll" ] 15 => array:2 [ "nombre" => "Julián" "apellidos" => "Segura" ] 16 => array:2 [ "nombre" => "Orlando" "apellidos" => "Gutiérrez" ] 17 => array:2 [ "nombre" => "Emilio" "apellidos" => "Sánchez" ] 18 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Ferreiro" ] 19 => array:2 [ "nombre" => "Rafael" "apellidos" => "García-Maset" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699520301818" "doi" => "10.1016/j.nefro.2020.11.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699520301818?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251421000420?idApp=UINPBA000064" "url" => "/20132514/0000004100000002/v1_202106220601/S2013251421000420/v1_202106220601/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2013251421000286" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2021.04.001" "estado" => "S300" "fechaPublicacion" => "2021-03-01" "aid" => "726" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2021;41:220-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "220" "paginaFinal" => "222" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Inmunoglobulinas por vía intravenosa: una alternativa terapéutica a tener en cuenta en el paciente trasplantado renal con COVID-19" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1145 "Ancho" => 1500 "Tamanyo" => 151520 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Chest X-ray showing the patient's radiological course during his first admission (A–B) and his second admission (C–D).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Abraham David Sánchez Cadena, Martín Negreira Caamaño, Raúl Pérez Serrano, María Lourdes Porras Leal" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Abraham David" "apellidos" => "Sánchez Cadena" ] 1 => array:2 [ "nombre" => "Martín" "apellidos" => "Negreira Caamaño" ] 2 => array:2 [ "nombre" => "Raúl" "apellidos" => "Pérez Serrano" ] 3 => array:2 [ "nombre" => "María Lourdes" "apellidos" => "Porras Leal" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699520300655" "doi" => "10.1016/j.nefro.2020.05.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699520300655?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251421000286?idApp=UINPBA000064" "url" => "/20132514/0000004100000002/v1_202106220601/S2013251421000286/v1_202106220601/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Is the immune hyporesponsiveness of uraemic patients a protective factor for severe COVID-19 pneumonia?" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "223" "paginaFinal" => "224" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Enrique A. Florit, Fritz Diekmann" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Enrique A." "apellidos" => "Florit" "email" => array:1 [ 0 => "kiqueflorit@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Fritz" "apellidos" => "Diekmann" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Instituto de Nefrología y Urología (ICNU), Hospital Clinic, Barcelona, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "¿Es la hiporrespuesta inmune de la uremia un factor de protección contra la neumonía grave por COVID-19?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">COVID-19/SARS-CoV-2 infection is a serious health problem with an unprecedented social and political response. The clinical expression of this new disease has been defined in the general population.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> However, few articles have been published on this infection in patients with chronic kidney disease with or without renal replacement therapy (RRT).</p><p id="par0010" class="elsevierStylePara elsevierViewall">A group from China published an interesting report of their experience at a haemodialysis centre. None of their 37 positive cases with a mean age of 66 years (55-81) had serious pneumonia. The six deaths from COVID-19 were attributed to other causes (cardiovascular and hyperkalaemia), with a death/infection rate of 16%. The authors considered this outcome less aggressive than expected in these frail patients, and it was attributed to their abnormal cellular immunity and inability to develop a “cytokine storm”.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The Sociedad Española de Nefrología (S.E.N.) [Spanish Society of Nephrology] has created a registry of COVID-19 cases. In the report of April 11, included 868 patients, mean age 67 years ±15, on RRT. A 72% developed pneumonia and approximately 5% required mechanical ventilation (10% were admitted ti intensive care unit (ICU).<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> This represented a death/infection rate of 22.7% (69.5% haemodialysis, 3.5% peritoneal dialysis and 26.8% kidney transplanted patients) — i.e. 7% higher than reported by the group from China, possibly differences in epidemiology and comorbidity – were not reported, plus they presented a larger number of cases. Comparison of this death/infection rate with the Spanish Ministry of Health data, which includes all cases in Spain, reveals that this rate is approximately 12% higher in patients on RRT. These data are dynamic and of debatable reliability since it is process subject to constant change, however the definitive numbers might be close to the data presented.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Patients with kidney diseases have an abnormal immune response. The main factors involved are the toxicity of uraemia, abnormal kidney metabolism of immune system molecules and the effects of RRT (materials used in dialysis, fluids, immunosuppressant drugs, etc.). Various forms of dysfunction have been reported in uraemic patients: monocyte senescence, B and T cell lymphopenia, deficient activation of lymphocytes secondary to increased apoptosis, reduced co-stimulation signal on the part of antigen-presenting cells, epigenetic changes in white blood cells and haematopoietic stem cells, and an accumulation of inflammatory cytokines (IL-1β, IL-18, IL-6, IL-8 and TNFα). These, along with an increase in oxidative stress, are the cause of a situation of chronic inflammation.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">An article by Ma et al. found that the count of T cell, T helper (Th) cells, cytotoxic killer T cells, natural killer (NK) cells and B lymphocytes were lower in haemodialysis patients with COVID-19 than in patients with COVID-19 without chronic kidney disease, and healthy controls. In addition, IL-4, IL-6 and TNFα levels were lower in patients with COVID-19 on haemodialysis than in all other comparator groups.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">Moreover, prior studies with related viruses (SARS and MERS) in the general population have found that the serious cases presented very high cytokine levels,<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> a pathophysiological condition known as a “cytokine storm”. This excessive response results in suppression of immunological activity, cardiovascular instability, metabolic acidosis and massive cell damage, which is characteristic of many septic states and it is independent of the aetiology.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Some drugs (IL-7, steroids, anakinra and others) have been used to mitigate this exaggerated immune response; and, in kidney patients we have extracorporeal blood (EBPTs) to combat sepsis, especially with the use high-adsorption membranes such as CytoSorb®, AN69 or oXiris®.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7,8</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">While the quantity and quality of scientific evidence for making recommendations on the use of EBPTs in sepsis is insuffcient and non uniform, it is important to stress that most studies have been conducted in patients with bacterial sepsis. In cases of serious viral infection, such as influenza A infection, it has been found to be beneficial. It has been found to have the potential to remove Ebola virus with a system of lectin affinity plasmapheresis.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,10</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">As COVID-19 research continues, from a clinical perspective efforts must continue to be made to join forces to acquire knowledge and gain experience at a faster-than-usual pace. One contribution that nephrologists might make would be to promote and assist with early use of l continuous extracorporeal purification techniques in seriously ill patients in the general population, as well as in nephrology patients. Nephrologists might also share their knowledge and experience in managing the hypercoagulability of COVID-19 patients that could interfere with blood purification techniques. Finally, the information obtained at the different centres that have tested these techniques and other treatments should be orchestrated and shared swiftly by international scientific associations.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "⋆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Florit EA, Diekmann F. ¿Es la hiporrespuesta inmune de la uremia un factor de protección contra la neumonía grave por COVID-19?. Nefrologia. 2021;41:223–224.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical characteristics of coronavirus disease 2019 in China" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.J. Guan" 1 => "Z.Y. Ni" 2 => "Y. Hu" 3 => "W.-H. Liang" 4 => "C.-Q. Ou" 5 => "J.-X. He" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2002032" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2020" "volumen" => "382" "paginaInicial" => "1708" "paginaFinal" => "1720" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32109013" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. Ma" 1 => "B. Diao" 2 => "X. Lv" 3 => "J. Zhu" 4 => "W. Liang" 5 => "L. Liu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1101/2020.02.24.20027201" "Revista" => array:4 [ "tituloSerie" => "medRxiv" "fecha" => "2020" "paginaInicial" => "2020" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33236033" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo Informe del Registro COVID-19 de la Sociedad Española de Nefrología (SEN)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Emilio Sánchez-Álvarez" 1 => "M.P. Fontán" 2 => "C.J. Martín" 3 => "M.B. Pelícano" 4 => "C.J.C. Reina" 5 => "Prieto ÁMS" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nefro.2020.04.002" "Revista" => array:3 [ "tituloSerie" => "Nefrologia" "fecha" => "2020" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11217655" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impaired cellular immune function in patients with end-stage renal failure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Girndt" 1 => "U. Sester" 2 => "M. Sester" 3 => "H. Kaul" 4 => "H. Kohler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/14.12.2807" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "1999" "volumen" => "14" "paginaInicial" => "2807" "paginaFinal" => "2810" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10570074" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immune dysfunction in Uremia – an update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Cohen" 1 => "W.H. Hörl" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Toxins (Basel)" "fecha" => "2012" "volumen" => "4" "paginaInicial" => "962" "paginaFinal" => "990" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Huang" 1 => "Y. Wang" 2 => "X. Li" 3 => "L. Ren" 4 => "J. Zhao" 5 => "Y. Hu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(20)30183-5" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2020" "volumen" => "395" "paginaInicial" => "497" "paginaFinal" => "506" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31986264" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Extracorporeal blood purification therapies for sepsis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Monard" 1 => "T. Rimmelé" 2 => "C. Ronco" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood Purif" "fecha" => "2019" "volumen" => "47" "numero" => "Suppl. 3" "paginaInicial" => "S2" "paginaFinal" => "S15" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemoadsorption by CytoSorb in septic patients: a case series" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "K. Kogelmann" 1 => "D. Jarczak" 2 => "M. Scheller" 3 => "M. Drüner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s13054-016-1589-6" "Revista" => array:6 [ "tituloSerie" => "Crit Care" "fecha" => "2017" "volumen" => "21" "paginaInicial" => "1" "paginaFinal" => "10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28057037" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "X. Liu" 1 => "Y. Zhang" 2 => "X. Xu" 3 => "W. Du" 4 => "K. Su" 5 => "C. Zhu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/1744-9987.12240" "Revista" => array:6 [ "tituloSerie" => "Ther Apher Dial" "fecha" => "2015" "volumen" => "19" "paginaInicial" => "178" "paginaFinal" => "184" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25363618" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Extracorporeal virus elimination for the treatment of severe Ebola virus disease – first experience with lectin affinity plasmapheresis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Büttner" 1 => "B. Koch" 2 => "O. Dolnik" 3 => "M. Eickmann" 4 => "T. Freiwald" 5 => "S. Rudolf" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000375229" "Revista" => array:6 [ "tituloSerie" => "Blood Purif" "fecha" => "2014" "volumen" => "38" "paginaInicial" => "286" "paginaFinal" => "291" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25676045" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000004100000002/v1_202106220601/S2013251421000274/v1_202106220601/en/main.assets" "Apartado" => array:4 [ "identificador" => "35436" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000004100000002/v1_202106220601/S2013251421000274/v1_202106220601/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251421000274?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 12 | 6 | 18 |
2024 October | 54 | 38 | 92 |
2024 September | 79 | 34 | 113 |
2024 August | 87 | 63 | 150 |
2024 July | 57 | 37 | 94 |
2024 June | 52 | 39 | 91 |
2024 May | 75 | 42 | 117 |
2024 April | 63 | 26 | 89 |
2024 March | 44 | 20 | 64 |
2024 February | 51 | 39 | 90 |
2024 January | 34 | 19 | 53 |
2023 December | 32 | 26 | 58 |
2023 November | 56 | 60 | 116 |
2023 October | 48 | 34 | 82 |
2023 September | 42 | 37 | 79 |
2023 August | 57 | 29 | 86 |
2023 July | 60 | 31 | 91 |
2023 June | 52 | 20 | 72 |
2023 May | 59 | 30 | 89 |
2023 April | 53 | 32 | 85 |
2023 March | 50 | 28 | 78 |
2023 February | 46 | 26 | 72 |
2023 January | 53 | 35 | 88 |
2022 December | 69 | 42 | 111 |
2022 November | 80 | 50 | 130 |
2022 October | 77 | 67 | 144 |
2022 September | 53 | 41 | 94 |
2022 August | 46 | 45 | 91 |
2022 July | 59 | 58 | 117 |
2022 June | 63 | 47 | 110 |
2022 May | 55 | 30 | 85 |
2022 April | 55 | 43 | 98 |
2022 March | 60 | 51 | 111 |
2022 February | 52 | 35 | 87 |
2022 January | 71 | 68 | 139 |
2021 December | 60 | 52 | 112 |
2021 November | 38 | 33 | 71 |
2021 October | 58 | 62 | 120 |
2021 September | 48 | 65 | 113 |
2021 August | 40 | 50 | 90 |
2021 July | 46 | 47 | 93 |
2021 June | 53 | 32 | 85 |
2021 May | 65 | 61 | 126 |
2021 April | 25 | 7 | 32 |